Evolving Challenges in the Oncology Market
Oncology is one of the fastest-growing areas of pharmaceutical and biopharmaceutical innovation. There is enthusiasm in many types of cancer studies, thanks to ongoing innovation and breakthroughs in advanced therapy options to help address diversity gaps, improved screening techniques and expanded clinical trial enrollment. Such advances are contributing to steady improvement in terms of both overall survival (OS) and progression-free survival (PFS) metrics within many forms of cancer.
With advancements reshaping the treatment landscape, there’s a unique set of challenges that come with adopting new technologies. Key challenges include:
- Accelerated approvals requiring the completion of post-marketing confirmatory studies with a positive outcome.
- New genomic testing and innovation in the treatment paradigm.
- Rapid changes in data create an information overload for treating physicians